A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

A first-of-its-kind gene therapy dramatically reduced misfolded protein levels in some clinical trial participants ... “It is quite remarkable that this first [intravenous] CRISPR-based gene-editing ...

Enter the anti-CRISPR protein AcrVIB1, a promising inhibitor whose exact function has remained a mystery—until now. A research team from the Helmholtz Institute for RNA-based Infection Research ...

Using the CRISPR/Cas9 genome-editing system to mutate the gene regions encoding particular protein domains could result in a new and more efficient method to screen for druggable protein targets ...

This protein can easily be programmed to find and bind to almost any desired target sequence, simply by giving it a piece of RNA to guide it in its search. When the CRISPR Cas9 protein is added to ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

as a promising universal treatment for DMD through a homologous protein activation approach. Exploration of dsRNA interactome using the K1 antibody and functional studies using CRISPR-Cas9 ...

Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...